These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 11135320

  • 1. Antibody constructs for radioimmunodiagnosis and treatment of human pancreatic cancer.
    Goel A, Batra SK.
    Teratog Carcinog Mutagen; 2001; 21(1):45-57. PubMed ID: 11135320
    [Abstract] [Full Text] [Related]

  • 2. Single-chain antibodies in pancreatic cancer.
    Colcher D, Pavlinkova G, Beresford G, Booth BJ, Batra SK.
    Ann N Y Acad Sci; 1999 Jun 30; 880():263-80. PubMed ID: 10415872
    [Abstract] [Full Text] [Related]

  • 3. A CDR-grafted (humanized) domain-deleted antitumor antibody.
    Slavin-Chiorini DC, Kashmiri SV, Lee HS, Milenic DE, Poole DJ, Bernon E, Schlom J, Hand PH.
    Cancer Biother Radiopharm; 1997 Oct 30; 12(5):305-16. PubMed ID: 10851481
    [Abstract] [Full Text] [Related]

  • 4. Experimental approaches to increase radiolabeled antibody localization in tumors.
    Buchsbaum DJ.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5729s-5732s. PubMed ID: 7493336
    [Abstract] [Full Text] [Related]

  • 5. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ, Rogers BE, Khazaeli MB, Mayo MS, Milenic DE, Kashmiri SV, Anderson CJ, Chappell LL, Brechbiel MW, Curiel DT.
    Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of Efficacy of Radioimmunotherapy with 90Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models.
    Sugyo A, Tsuji AB, Sudo H, Okada M, Koizumi M, Satoh H, Kurosawa G, Kurosawa Y, Saga T.
    PLoS One; 2015 Oct 01; 10(4):e0123761. PubMed ID: 25893775
    [Abstract] [Full Text] [Related]

  • 7. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G, Buchegger F, Waibel R, Kuenzi G, Offord RE, Schubiger PA, Gillet M, Delaloye AB.
    Cancer Biother Radiopharm; 2001 Oct 01; 16(5):371-9. PubMed ID: 11776754
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D, Pavlinkova G, Beresford G, Booth BJ, Choudhury A, Batra SK.
    Q J Nucl Med; 1998 Dec 01; 42(4):225-41. PubMed ID: 9973838
    [Abstract] [Full Text] [Related]

  • 9. 99mTc-labeled divalent and tetravalent CC49 single-chain Fv's: novel imaging agents for rapid in vivo localization of human colon carcinoma.
    Goel A, Baranowska-Kortylewicz J, Hinrichs SH, Wisecarver J, Pavlinkova G, Augustine S, Colcher D, Booth BJ, Batra SK.
    J Nucl Med; 2001 Oct 01; 42(10):1519-27. PubMed ID: 11585867
    [Abstract] [Full Text] [Related]

  • 10. [Immunoscintigraphy and radioimmunotherapy of transplanted pancreatic carcinoma. Experimental animal studies with 131I-labeled monoclonal antibodies against CA 19-9, CEA and CA 125].
    Klapdor R, Montz R, Greten H, Chatal JF, Douillard JY, Saccavini JC, Dietel M.
    Nuklearmedizin; 1985 Dec 01; 24(5-6):227-31. PubMed ID: 3867855
    [Abstract] [Full Text] [Related]

  • 11. Biodistribution of murine and chimeric Fab fragments of the monoclonal antibody A7 in human pancreatic cancer.
    Otsuji E, Yamaguchi T, Yamaoka N, Kotani T, Kato M, Taniguchi K, Kiyamura K, Takahashi T.
    Pancreas; 1995 Apr 01; 10(3):265-73. PubMed ID: 7624304
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B, Siegel SE, Kaiser HE.
    Anticancer Res; 1996 Apr 01; 16(2):661-74. PubMed ID: 8687112
    [Abstract] [Full Text] [Related]

  • 17. Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.
    Rogers BE, Roberson PL, Shen S, Khazaeli MB, Carpenter M, Yokoyama S, Brechbiel MW, LoBuglio AF, Buchsbaum DJ.
    Cancer Biother Radiopharm; 2005 Oct 01; 20(5):502-13. PubMed ID: 16248766
    [Abstract] [Full Text] [Related]

  • 18. Antibodies in the therapy of colon cancer.
    Welt S, Ritter G.
    Semin Oncol; 1999 Dec 01; 26(6):683-90. PubMed ID: 10606261
    [Abstract] [Full Text] [Related]

  • 19. New concepts in monoclonal antibody based radioimmunodiagnosis and radioimmunotherapy of carcinoma.
    Schlom J, Milenic DE, Roselli M, Colcher D, Bird R, Johnson S, Hardman KD, Guadagni F, Greiner JW.
    Int J Rad Appl Instrum B; 1991 Dec 01; 18(4):425-35. PubMed ID: 1864731
    [Abstract] [Full Text] [Related]

  • 20. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ, Khazaeli MB, Mayo MS, Roberson PL.
    Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.